Total Funding
67
68
Total FundingSeries A raised
Growth Score
-9 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39599
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
- Dan Brounstein: CEO and Board MemberPast Role: Spinal Modulation, VP, Marketing & VP, Clinical Operations
- Stephen Masson: Co-Founder
About the Company
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs. It focuses on commercializing neuromodulation technology platforms designed to treat patients suffering from chronic diseases.
